SSY GROUP (02005) has obtained the drug manufacturing registration approval from the National Medical Products Administration for Levofloxacin Drops (0.488% (5ml: 24.4mg)).

12:10 09/12/2025

Shi Si Pharmaceutical Group (02005) announced that the group has obtained the drug production registration certificate for Levofloxacin Eye Drops (0.488% (5ml: 24.4mg)) from the National Medical Products Administration of China (NMPA), which belongs to the category 4 of chemical drugs and is considered to have passed the consistency evaluation. Levofloxacin Eye Drops are mainly used for the treatment of blepharitis, meibomian gland dysfunction, dacryocystitis, conjunctivitis, meibomitis, keratitis, and for sterile therapy during the perioperative period in ophthalmology. This approval has enriched the variety of eye preparations in the group.

SSY Group (02005) announces that the group has obtained the drug production registration certificate for levofloxacin eye drops (0.488% (5ml: 24.4mg)) from the China National Medical Products Administration (NMPA), which belongs to the category 4 chemical drugs and is considered to have passed consistency evaluation. Levofloxacin eye drops are mainly used to treat blepharitis, meibomian gland inflammation, lacrimal sac inflammation, conjunctivitis, hordeolum, keratitis, as well as for sterile therapy in ophthalmic perioperative period. This approval enriches the variety of ophthalmic preparations of the group. The Board of Directors is pleased to announce that the group has also obtained NMPA's approval for compound pico sodium sulfate granules (each bag containing 10mg of pico sodium sulfate), which belongs to the category 3 chemical drugs and is considered to have passed consistency evaluation. Compound pico sodium sulfate granules are mainly used for colonoscopy and X-ray examination preparation, and can also be used to clean the intestines before surgery. As announced on December 4, 2025, the pico sodium sulfate active pharmaceutical ingredient of the group has been registered and approved by NMPA to be used as a raw material in marketed preparations.

New Stock News | Galaxy General denies rumors of listing in Hong Kong: Stock reform is for future financing needs.

Ten thousand securities: the securities industry still has room for incremental business and it is suggested to focus on small and medium-sized securities firms with prominent sub-tracks.

HK Stock Market Move | CMOC Group Limited (03993) fell more than 7% in the afternoon, reportedly due to the latest cobalt export regulations introduced by the Democratic Republic of Congo exacerbating industry skepticism.

New Stock News | Galaxy General denies rumors of listing in Hong Kong: Stock reform is for future financing needs.

Ten thousand securities: the securities industry still has room for incremental business and it is suggested to focus on small and medium-sized securities firms with prominent sub-tracks.